Bio Pharma Dive
MAY 24, 2022
One day after the U.S. began releasing supplies of an approved Bavarian Nordic shot, Moderna said it's beginning development of its own vaccine against the virus.
World of DTC Marketing
MAY 27, 2022
According to the National Institutes of Health, people with a mental health diagnosis committed less than 5 percent of gun-related homicides between 2001 and 2010. Mental health experts, including representatives from the American Psychological Association, have called it “unfounded” to blame mass shootings on mental illness in place of considering other possible factors, such as hate, bigotry, and access to assault weapons.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 24, 2022
The pharma industry is becoming an increasingly hot commodity for cybercriminals. In recent years, digital adoption has accelerated at a rapid pace, with companies racing to integrate cloud-based platforms and telehealth services to expand the delivery of modern healthcare. Combined with the sudden arrival of COVID-19, this perfect storm of events handed cybercriminals an opportunity to exploit weaknesses in fledging systems and processes.
Worldwide Clinical Trials
MAY 24, 2022
Life after cancer is about more than just survival. It’s not just the length of life that matters, but also the quality of that life. Join us as we celebrate cancer research awareness month and clinical trials awareness month. Building Bridges. Where I trained at the University of Maryland, there was literally a bridge that connected the research labs to the clinic.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
MAY 26, 2022
Bristol Myers beat Merck to the first approval of a so-called LAG-3 inhibitor.
World of DTC Marketing
MAY 24, 2022
Cerebral will stop writing prescriptions for Adderall, Ritalin, and other controlled substances to new ADHD patients as concerns grow about telehealth companies’ prescribing practices. To make matters worse, a former executive at Cerebral, a well-funded online mental health startup, claims in a labor lawsuit that the company fired him after he complained that the company was too quick to prescribe powerful stimulant drugs.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
MAY 25, 2022
US pharma giant Pfizer has said it will sell some of its patented medicines at non-profit prices to 45 of the world’s poorest countries – including new launches. The initiative will focus on infectious diseases, cancer, inflammation, rare diseases and women’s health, and will include its BioNTech-partnered COVID-19 vaccine Comirnaty as well as oral antiviral therapy Paxlovid (nirmatrelvir/ritonavir).
Bio Pharma Dive
MAY 26, 2022
Fresh study results showed similar rates of response and progression-free survival with Mirati's experimental adragasib as with Amgen's approved Lumakras. The new data might raise safety questions, however.
World of DTC Marketing
MAY 25, 2022
Gun violence isn’t just a criminal justice issue; it’s a public health issue. There was nearly a 30 percent increase in homicides between 2019 and 2020, making it the most significant one-year increase in six decades. The number of gun deaths in 2021 climbed even higher and is approaching the previous peaks in gun death rates in the early 1970s and early 1990s. .
Pharma Times
MAY 24, 2022
Less invasive procedure offers an equally effective alternative for heart condition patients
BioPharma Reporter
MAY 23, 2022
The potential of cell therapy is proven, but its impact is limited by manufacturing bottlenecks.
Bio Pharma Dive
MAY 26, 2022
Detailed results from important studies of AstraZeneca’s breast cancer drug Enhertu, Gilead’s Trodelvy and Roche’s TIGIT blocker are among the most anticipated late-breaking data set to be presented next month.
pharmaphorum
MAY 25, 2022
After more than six years of development, Angle has scored an FDA approval for Parsortix as a diagnostic for metastatic breast cancer – the first ever in the US for a device used to detect cancer by harvesting cells from a patient blood sample. In a statement , the UK medical device firm said its “liquid biopsy” approach “offers the prospect of a new era of personalised cancer care” and moves it closer to positioning Parsortix as a go-to technology for assessing cancer st
Pharma Times
MAY 27, 2022
Initial group of patients have received Saphnelo in a phase 3 trial evaluating lupus nephritis
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
XTalks
MAY 25, 2022
Fibromyalgia is a chronic condition that causes widespread pain, difficulty concentrating, sleep problems, fatigue, mood disorders and other symptoms. People with fibromyalgia have abnormal pain perception processing, so they may be more sensitive to pain compared to people without the condition. Fibromyalgia affects approximately 4 million adults in the US, which is about 2 percent of the US adult population.
Bio Pharma Dive
MAY 25, 2022
The regulator agreed to assess the companies' data under priority review, setting up a decision on approval of the hemophilia B treatment in six months.
pharmaphorum
MAY 24, 2022
Data is the powerhouse of the pharmaceutical sector. It powers drug discovery, clinical trials, and operational performance. But sizeable reservoirs of data remain unseen and untapped to commercial operations, allowing insights, opportunities, and efficiencies to leak away. Organisations are missing out on the ability to harness their data to energise precision marketing and transform commercial performance.
Pharma Times
MAY 25, 2022
Technology is already being used in clinical trials of new treatments for Alzheimer’s and new studies will provide additional validation
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
XTalks
MAY 27, 2022
World Hunger Day is observed each year on May 28 to raise awareness about the dramatic rise in hunger in recent years. While the day was created prior to the COVID-19 pandemic, the unprecedented global crisis has forced hundreds of millions of people into chronic hunger, escalating the need for change. Here’s everything you need to know about World Hunger Day 2022.
Bio Pharma Dive
MAY 23, 2022
There are no treatments specifically approved for alopecia areata. Concert follows Pfizer and Eli Lilly in reporting positive late-stage results for drugs they're developing for the autoimmune disorder.
pharmaphorum
MAY 23, 2022
This article follows part one of our two-part series, in which we discussed how USAID invests in digital infrastructure as part of its development and humanitarian assistance programmes. . Adele Waugaman, senior digital health coordinator of the COVID-19 response at the United States Agency for International Development (USAID), discusses the value of establishing donor partnerships and how those collaborations can improve digital health options globally. .
Pharma Times
MAY 27, 2022
Faricimab is administered as an eye injection with an interval of up to 16 weeks
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
XTalks
MAY 26, 2022
The US FDA approved Dupixent (dupilumab) developed by Regeneron as the first treatment for eosinophilic esophagitis, a chronic immune disorder that damages the esophagus. Eosinophilic Esophagitis (EoE) is a chronic inflammatory disease caused by type 2 (allergic) inflammation. An overreaction of the immune system recruits eosinophils, a type of white blood cell, to the esophagus, resulting in inflammation as they respond to the “threat”.
Bio Pharma Dive
MAY 26, 2022
Bosley, who once led the CRISPR gene editing biotech, will become a venture partner at Advent Life Sciences, which backs a range of early-stage drug companies.
pharmaphorum
MAY 25, 2022
The move to online international meetings has left pharma companies with uncertainty around contact compliance. But new joint guidance, from the IFPMA, EFPIA, and PhRMA, provides clarity. To say the world of work has changed is something of an understatement in the pharma and biopharma industry. Since COVID-19 reared its head more than two years ago, the traditional hustle and bustle of in-person annual congresses have largely been consigned to the history books.
Pharma Times
MAY 23, 2022
Positive opinion is based on data from clinical trials which showed improvement in lung function
Drug Patent Watch
MAY 27, 2022
This chart shows the patent expirations for capsule dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…. The post Capsule dosed drug patent expirations by year appeared first on DrugPatentWatch - Make Better Decisions.
Bio Pharma Dive
MAY 23, 2022
As with treatment, and even adherence, there is no 'one size fits all' when it comes to patient engagement.
pharmaphorum
MAY 26, 2022
The co-founder of Los Angeles biotech Enochian Biosciences has been arrested in connection with a federal investigation into the murder of a Vermont man in 2018. Serhat Gümrükcü (39) has been charged with conspiring to use interstate commerce facilities in the commission of murder-for-hire, along with alleged co-conspirator Berk Eratay (35) of Las Vegas.
Pharma Times
MAY 26, 2022
Libtayo has been approved for adults when curative surgery or radiation is not appropriate
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Expert insights. Personalized for you.
345 
Let's personalize your content